On March 1, 2022, David Dornan, Ph.D. notified Bolt Biotherapeutics, Inc. of his resignation as the company's Chief Scientific Officer, effective from March 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.758 USD | -0.98% | -0.37% | -32.32% |
May. 20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
May. 20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.32% | 28.89M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+3.14% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics, Inc. Announces Resignation of David Dornan as Chief Scientific Officer, Effective from March 11, 2022